Abstract
Optic neuropathy can be a result of congenital or acquired causes. Acquired causes can be inflammatory, ischaemic, compressive or nutritional. Hereditary causes such as Leber’s Hereditary Optic Neuropathy and Autosomal Dominant Optic Neuropathy can present as acquired optic neuropathies. For the purpose of this chapter, the common and more serious causes of optic neuropathy have been discussed.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abel A, McClelland C, Lee MS. Critical review: typical and atypical optic neuritis. Surv Ophthalmol. 2019;64(6):770–9. https://doi.org/10.1016/j.survophthal.2019.06.001.
Beck RW, Cleary PA, Anderson MM, et al. A randomized, controlled trial of corticosteroids in the treatment of acute optic neuritis. N Engl J Med. 1992;326:581–8. https://doi.org/10.1056/NEJM199202273260901.
Chen JJ, Pittock SJ, Flanagan EP, et al. Optic neuritis in the era of biomarkers. Surv Ophthalmol. 2019;65(1):12–7. https://doi.org/10.1016/j.survophthal.2019.08.001.
Dasgupta B, Borg FA, Hassan N, Alexander L, Barraclough K, Bourke B, Fulcher J, Hollywood J, Hutchings A, James P, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology. 2010;49(8):1594–7. https://doi.org/10.1093/rheumatology/keq039a.
Newman NJ, Scherer R, Langenberg P, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002;134:317–28. https://doi.org/10.1016/S0002-9394(02)01639-2.
Smith SV, Friedman DI. The idiopathic intracranial hypertension treatment trial: a review of the outcomes. Headache. 2017;57:1303–10. https://doi.org/10.1111/head.13144.
Fu Z, Hong H, Su Z, et al. Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis. Br J Ophthalmol. 2019. pii: bjophthalmol-2019-314759. https://doi.org/10.1136/bjophthalmol-2019-314759.
Li T, Qureshi R, Taylor K. Conventional occlusion versus pharmacologic penalization for amblyopia. Cochrane Database Syst Rev. 2009;(4):CD006460. https://doi.org/10.1002/14651858.CD006460.pub3.
Thurtell MJ, Leigh RJ. Therapy for nystagmus. J Neuroophthalmol. 2010;30:361–71. https://doi.org/10.1097/WNO.0b013e3181e7518f.
Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375:2570–81. https://doi.org/10.1056/NEJMra1602678.
Nagia L, Lemos J, Abusamra K, et al. Prognosis of ocular myasthenia gravis: retrospective multicenter analysis. Ophthalmology. 2015;122:1517–21. https://doi.org/10.1016/j.ophtha.2015.03.010.
Davagnanam I, Fraser C, Miszkiel K, et al. Adult Horner’s syndrome: a combined clinical, pharmacological, and imaging algorithm. Eye. 2013;27:291–8. https://doi.org/10.1038/eye.2012.281.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Lee, H., Bates, A. (2020). Neuro-ophthalmology and Strabismus. In: Liu, C., Lee, H. (eds) Fundamentals in Ophthalmic Practice . Springer, Cham. https://doi.org/10.1007/978-3-030-28841-9_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-28841-9_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28840-2
Online ISBN: 978-3-030-28841-9
eBook Packages: MedicineMedicine (R0)